Paul Mahon's Stock Option Exercise and Sales at United Therapeutics Corporation

Paul Mahon, an officer at United Therapeutics Corporation, has exercised stock options and sold shares of the company's common stock. The filing details the exercise of 11,000 stock options on October 16, 2025, with the shares acquired on the same date. Additionally, the filing reports multiple sales of 11,000 shares each over the past three months, with the most recent sale occurring on October 2, 2025, generating gross proceeds of $4,802,572.50. The aggregate market value of the shares sold on October 16, 2025, is $4,746,493.40. The transactions were executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing also indicates that the plan for these transactions was adopted on December 24, 2024.